Julie Tierney is returning to a familiar area of the US Food and Drug Administration for a new role, moving from the Office of the Commissioner back to the Center for Biologics Evaluation and Research.
The agency announced on 15 November that Tierney, who is the FDA’s chief of staff, will become CBER’s deputy director...






